Royal Philips reported Q2 2026 sales of EUR 4.4 billion (+4% comparable), with an adjusted EBITA margin of 16.4% — far above analyst expectations of 11.9% — driven largely by a EUR 186 million US tariff refund. Three business segments all posted comparable sales growth: Diagnosis & Treatment (+2%), Connected Care (+...

Create a landscape editorial hero image for this Studio Global article: Search & fact-check with cited sources for What were the key financial results of Royal Philips in Q2 2026, including group sales, comparabl. Article summary: Royal Philips reported its Q2 2026 results on July 27, 2026. The quarter was marked by solid comparable sales growth, a significant margin expansion driven partly by a US tariff refund, and upwardly revised full-year gui. Topic tags: general, government, news, general web, user generated. Style: premium digital editorial illustration, source-backed research mood, clean composition, high detail, modern web publication hero. Use reference image context only for broad subject, composition, and topical grounding; do not copy the exact image. Avoid: logos, brand marks, copyrighted characters, real person likenesses, fake screenshots, UI text, readable text, watermar
Royal Philips reported its Q2 2026 results on July 27, 2026, delivering solid comparable sales growth and a significant margin expansion fueled by a US tariff refund. The company also raised its full-year 2026 guidance for adjusted EBITA margin and free cash flow. Here is the detailed breakdown.
Philips operates three core business segments, all of which contributed to the quarter's growth:
The single biggest story of the quarter was a EUR 186 million (USD 211.5 million) refund from the US government for tariffs that Philips had overpaid in prior periods . This refund was included in income from operations and had an outsized effect on profitability.
Reflecting the benefit of the tariff refund, Philips raised its full-year 2026 financial outlook :
Philips held its scheduled conference call for investors and analysts on July 27, 2026, immediately following the publication of the results .
Studio Global AI
Use this topic as a starting point for a fresh source-backed answer, then compare citations before you share it.
Royal Philips reported Q2 2026 sales of EUR 4.4 billion (+4% comparable), with an adjusted EBITA margin of 16.4% — far above analyst expectations of 11.9% — driven largely by a EUR 186 million US tariff refund.
Royal Philips reported Q2 2026 sales of EUR 4.4 billion (+4% comparable), with an adjusted EBITA margin of 16.4% — far above analyst expectations of 11.9% — driven largely by a EUR 186 million US tariff refund. Three business segments all posted comparable sales growth: Diagnosis & Treatment (+2%), Connected Care (+5%), and Personal Health (+6%).